medigraphic.com
ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2019, Number 3

<< Back Next >>

Rev Latin Infect Pediatr 2019; 32 (3)

Chickenpox: Is it better to get immunized with the disease than with the vaccine?

Mascareñas‑de los Santos AH, Vaquera‑Aparicio DN, De la O‑Cavazos ME, Castillo‑Bejarano JI

Language: Spanish
References: 14
Page: 96-99
PDF size: 146.94 Kb.


ABSTRACT

Chickenpox is an important cause of morbidity and mortality. Vaccination plays a decisive role in reducing the number of cases and related complications. The present text will analyze the complications caused by chickenpox compared with the adverse effects associated with the vaccine.


REFERENCES

  1. Mandell GL, Bennett JE, Dolin R. Enfermedades infecciosas, principios y práctica. 8a ed. Barcelona, Elsevier. 2015.

  2. Hernández PM. Varicela en vacunación: niños, adolescentes, adultos e inmunocomprometidos. Ed. Medicina, Publicidad y Mercadotecnia, S.A. de C.V, CDMX, México 2017. pp.129-139.

  3. Bardach A et al. Incidence and use of resources for chickenpox and herpes zoster in Latin America and the Caribbean: a systematic review and meta-analysis. Pediatr Infect Dis J. 2012; 31: 1263-1268.

  4. Vergara-Castañeda A et al. Epidemiology of varicella in Mexico. J Clin Virol. 2012; 55: 51-57.

  5. Vázquez M, Cravioto P, Galván F, Guarneros D, Pastor VH. Varicela y herpes zóster: retos para la salud pública. Salud Pública Mex. 2017; 59: 650-656.

  6. Cabrera-Gaytán DA, Muñoz-Mendoza W, Gómez-Altamirano CM. Comportamiento epidemiológico de la varicela en México: 18 años de estudios y estimaciones para los próximos 5 años. Rev Enfer Infec Pediatr. 2009; 22.23 (87): 77-82.

  7. Macias-Parra M et al. Economic burden of varicella complications in two referral centers in Mexico. Hum Vaccin Immunother. 2018; 29: 1-5

  8. Ávila-Aguero M et al. Varicella epidemiology in Latin America and the Caribbean. Expert Rev Vaccines. 2017; 17 (2): 175-183.

  9. Hamborsky J, Kroger A, Wolfe S. Epidemiology and prevention of vaccine-preventable diseases. 13th edition. Washington D.C.: Public Health Foundation; 2015.

  10. Varicella and herpes zoster vaccines: WHO position paper. Weekly epidemiological record. 2014.

  11. Galea SA et al. The safety profile of varicella vaccine: a 10-year review. J Infect Dis. 2008; 197: S165-169.

  12. Kowalzik F, Faber J, Knuf M. MMR and MMRV vaccines. Vaccine. 2017; 36 (36): 5402-5407.

  13. Navalkele BD et al. First case of vaccine strain varicella infection as manifestation of HIV in healthcare worker. A case report and review of the literature. J Hosp Infect. 2017; 97 (4): 384-388.

  14. Su JR et al. Safety of second-dose single-antigen varicella vaccine. Pediatrics. 2017; 139 (3): 2-8.




2020     |     www.medigraphic.com